resTORbio, Inc.

resTORbio, Inc.

resTORbio, Inc.

resTORbio is an advanced clinical stage company, developing medicines to treat agingrelated diseases and conditions.
Raised
$40M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Team Size
1–10
Employees
Xconomy

Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio

Xconomy

ResTORbio Shares Soar on Clinical Data From Lung Infection Drug

Health
FinSMEs

resTORbio Announces Initial Public Offering Pricing

Costs Stock markets Health